Medical biotechnology industry

February 25, 2019 - 8:29 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as it continues to sell off chunks of a once sprawling conglomerate. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. Danaher said after tax benefits,...
Read More
February 25, 2019 - 7:32 am
BOSTON (AP) — General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself. The biopharma unit, part of GE Life Sciences, generated revenue of about $3 billion last year. The mostly-cash transaction is expected to...
Read More
FILE- In this Nov. 20, 2018, file photo pedestrians walk past the New York Stock Exchange. The U.S. stock market opens at 9:30 a.m. EST on Friday, Nov. 30 (AP Photo/Mary Altaffer, File)
November 30, 2018 - 1:51 pm
NEW YORK (AP) — Stocks are wavering Friday ahead of the highly anticipated trade meeting between President Donald Trump and President Xi Jinping of China. Investors have long hoped the two will use their meeting at the Group of 20 summit to start resolving the trade dispute between the two...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 2:17 am
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8:20 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 09, 2018 - 12:24 am
NEW YORK (AP) — Republican U.S. Rep. Christopher Collins of New York was arrested Wednesday on charges he fed inside information he gleaned from sitting on the board of a biotechnology corporation to his son, helping family and friends dodge hundreds of thousands of dollars in losses when one of...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 08, 2018 - 8:46 pm
NEW YORK (AP) — Republican U.S. Rep. Christopher Collins of New York was arrested Wednesday on charges he fed inside information he gleaned from sitting on the board of a biotechnology corporation to his son, helping family and friends dodge hundreds of thousands of dollars in losses when one of...
Read More
Republican U.S. Rep. Christopher Collins, center, leaves federal court, Wednesday, Aug. 8, 2018, in New York. Rep. Collins of western New York state has been indicted on charges that he used inside information about a biotechnology company to make illicit stock trades (AP Photo/Mary Altaffer)
August 08, 2018 - 8:23 pm
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8:20 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a...
Read More
August 08, 2018 - 8:18 pm
NEW YORK (AP) — The Latest on insider-trading charges filed against U.S. Rep. Chris Collins (all times local): 8 p.m. Republican U.S. Rep. Chris Collins says he will remain on the ballot running for re-election in New York as he fights charges that he used inside information about a biotechnology...
Read More
This undated microscope image provided by the American Society for Reproductive Medicine in January 2018 shows a trophectoderm biopsy, in which cells from the outer layer of an embryo that develop into the placenta and amniotic membranes are removed and can be used for genetic testing. When a couple is known to be at risk for having a child with a specific genetic disorder, the woman undergoes a procedure to remove some of her eggs. After fertilization, some cells can be plucked from the embryos and examined to identify those without carry the disease-causing abnormality. (ASRM via AP)Wedn
April 18, 2018 - 1:11 am
NEW YORK (AP) — So you want to have a baby. Would you like a dark-haired girl with a high risk of someday getting colon cancer, but a good chance of above-average music ability? Or would you prefer a girl with a good prospect for high SAT scores and a good shot at being athletic, but who also is...
Read More
February 14, 2018 - 2:58 pm
CHICAGO (AP) — The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval. The move means Banyan Biomarkers can commercialize its test, giving the company an early lead in the biotech industry's race to find a way to diagnose concussions. The test doesn'...
Read More

Pages